{
    "clinical_study": {
        "@rank": "325",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 14, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04343261"
        },
        "id_info": {
            "org_study_id": "SFH-20-23",
            "nct_id": "NCT04343261"
        },
        "brief_title": "Convalescent Plasma in the Treatment of COVID 19",
        "official_title": "Convalescent Plasma in the Treatment of COVID 19",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Saint Francis Care",
                "agency_class": "Other"
            }
        },
        "source": "Saint Francis Care",
        "oversight_info": {
            "has_dmc": "No",
            "is_fda_regulated_drug": "Yes",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "The purpose of this study is to collect blood from previously COVID-19 infected persons who\n      have recovered and use it as a treatment for those who are currently sick with a severe or\n      life-threatening COVID-19 infection."
        },
        "detailed_description": {
            "textblock": "The purpose of this study is to collect blood from previously COVID-19 infected persons who\n      have recovered and use it as a treatment for those who are currently sick with a severe or\n      life-threatening COVID-19 infection."
        },
        "overall_status": "Not yet recruiting",
        "start_date": {
            "@type": "Anticipated",
            "#text": "April 10, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "April 1, 2021"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "December 1, 2020"
        },
        "phase": "Phase 2",
        "study_type": "Interventional",
        "has_expanded_access": "No",
        "study_design_info": {
            "intervention_model": "Single Group Assignment",
            "primary_purpose": "Treatment",
            "masking": "None (Open Label)"
        },
        "primary_outcome": [
            {
                "measure": "Mortality",
                "time_frame": "28 days",
                "description": "Mortality within 28 days"
            },
            {
                "measure": "Viral Load",
                "time_frame": "7 days",
                "description": "Reduction of Viral Load ]"
            },
            {
                "measure": "Serum Antibody Titers",
                "time_frame": "7 days",
                "description": "Change in Serum Antibody Titers"
            }
        ],
        "number_of_arms": "1",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "15"
        },
        "condition": [
            "SARS-CoV-2",
            "COVID",
            "Coronavirus"
        ],
        "arm_group": {
            "arm_group_label": "COVID-19 patients treated with convalescent plasma",
            "arm_group_type": "Experimental",
            "description": "Severely ill COVID-19 patients treated with convalescent plasma"
        },
        "intervention": {
            "intervention_type": "Biological",
            "intervention_name": "Convalescent Plasma",
            "description": "treatment with 2 Units of convalescent plasma",
            "arm_group_label": "COVID-19 patients treated with convalescent plasma"
        },
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All genders\n\n          -  Age > 18 yrs and < 90 yrs\n\n          -  Must have laboratory confirmed COVID-19\n\n          -  Must provide informed consent\n\n          -  Must have severe or immediately life-threatening COVID-19,\n\n        Severe disease is defined as:\n\n          -  dyspnea,\n\n          -  respiratory frequency \u2265 30/min,\n\n          -  blood oxygen saturation \u2264 93%,\n\n          -  partial pressure of arterial oxygen to fraction of inspired oxygen ratio < 300\n\n          -  lung infiltrates > 50% within 24 to 48 hours\n\n        Life-threatening disease is defined as:\n\n          -  respiratory failure,\n\n          -  septic shock\n\n          -  multiple organ dysfunction or failure\n\n        Exclusion Criteria:\n\n          -  No gender exclusion\n\n          -  Age < 18 yrs and > 90 yrs\n\n          -  COVID-19 negative"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "90 Years",
            "healthy_volunteers": "No"
        },
        "overall_contact": {
            "last_name": "Latha Dulipsingh, MD",
            "phone": "860-714-4402",
            "email": "Latha.Dulipsingh@trinityhealthofne.org"
        },
        "location": {
            "facility": {
                "name": "Trinity Health Of New England",
                "address": {
                    "city": "Hartford",
                    "state": "Connecticut",
                    "zip": "06105",
                    "country": "United States"
                }
            },
            "contact": {
                "last_name": "Latha Dulipsingh, MD",
                "phone": "860-714-4402"
            },
            "investigator": {
                "last_name": "Latha Dulipsingh, MD",
                "role": "Principal Investigator"
            }
        },
        "location_countries": {
            "country": "United States"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 8, 2020",
        "study_first_submitted_qc": "April 8, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "April 13, 2020"
        },
        "last_update_submitted": "April 12, 2020",
        "last_update_submitted_qc": "April 12, 2020",
        "last_update_posted": {
            "@type": "Estimate",
            "#text": "April 14, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "keyword": "SARS-CoV-1, COVID, Coronavirus, convalescent plasma, plasma",
        "condition_browse": {
            "mesh_term": "Coronavirus Infections"
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}